Viewing Study NCT04417894


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2025-12-26 @ 1:29 AM
Study NCT ID: NCT04417894
Status: COMPLETED
Last Update Posted: 2023-12-22
First Post: 2020-06-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)
Sponsor: Regeneron Pharmaceuticals
Organization: